Last 7 days
-9.9%
Last 30 days
-7.5%
Last 90 days
4.8%
Trailing 12 Months
4.5%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-06 | Carson Seana | sold | -55,351 | 8.28 | -6,685 | evp, general counsel |
2023-09-05 | Barresi John S | sold (taxes) | -33,249 | 8.35 | -3,982 | svp, controller & cao |
2023-09-05 | Vadaketh Tom George | sold (taxes) | -366,966 | 8.35 | -43,948 | evp, chief financial officer |
2023-09-05 | Carson Seana | sold (taxes) | -428,664 | 8.35 | -51,337 | evp, general counsel |
2023-09-01 | APPIO THOMAS | sold (taxes) | -119,379 | 8.46 | -14,111 | chief executive officer |
2023-06-30 | Paulson John | acquired | 62,496 | 8.00 | 7,812 | - |
2023-06-30 | ICAHN BRETT | acquired | 33,120 | 8.00 | 4,140 | - |
2023-06-30 | ROBERTSON RUSSEL C | acquired | 31,248 | 8.00 | 3,906 | - |
2023-06-30 | WECHSLER AMY B | acquired | 6,872 | 8.00 | 859 | - |
2023-06-20 | Barresi John S | sold (taxes) | -14,274 | 7.4 | -1,929 | svp, controller & cao |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-07 | ACADEMY CAPITAL MANAGEMENT INC/TX | reduced | -57.97 | -560,872 | 398,128 | 0.08% |
2023-08-24 | Alberta Investment Management Corp | reduced | -23.93 | -793,779 | 2,421,600 | 0.02% |
2023-08-23 | WOLVERINE TRADING, LLC | added | 55.79 | 149,484 | 405,484 | -% |
2023-08-23 | Stonebridge Capital Advisors LLC | reduced | -13.89 | -4,360 | 24,800 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -10.37 | -29,303 | 255,554 | -% |
2023-08-16 | GTS SECURITIES LLC | new | - | 930,872 | 930,872 | 0.03% |
2023-08-15 | Rokos Capital Management LLP | new | - | 14,078,100 | 14,078,100 | 0.14% |
2023-08-15 | IHT Wealth Management, LLC | reduced | -10.06 | -10,316 | 82,000 | -% |
2023-08-15 | LAZARD ASSET MANAGEMENT LLC | new | - | 49,000 | 49,000 | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 18.9 | 2,085,930 | 14,049,700 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | nomura holdings inc | 3.6% | 13,030,352 | SC 13G/A | |
Feb 13, 2023 | goldentree asset management lp | 5.4% | 19,421,054 | SC 13G | |
May 13, 2022 | va partners i, llc | 4.0% | 14,430,901 | SC 13D/A | |
Feb 14, 2022 | nomura holdings inc | 5.4% | 19,515,079 | SC 13G | |
Dec 13, 2021 | glenview capital management, llc | 4.75% | 17,078,657 | SC 13D/A | |
Jun 21, 2021 | va partners i, llc | 5.0% | 17,941,603 | SC 13D/A | |
Apr 23, 2021 | meruelo alex | 5.51% | 19,604,777 | SC 13G | |
Mar 16, 2021 | icahn carl c | 3.98% | 14,169,189 | SC 13D/A | |
Mar 11, 2021 | icahn carl c | 3.98% | 14,169,189 | SC 13D/A | |
Feb 24, 2021 | icahn carl c | - | 0 | SC 13D/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 18, 2023 | 8-K | Current Report | |
Sep 14, 2023 | 8-K | Current Report | |
Sep 11, 2023 | 8-K | Current Report | |
Sep 06, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 8-K | Current Report | |
Sep 05, 2023 | 4 | Insider Trading | |
Aug 03, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
LLY | 517.3B | 29.5B | 5.22% | 88.98% | 79.61 | 17.53 | 1.53% | 14.16% |
JNJ | 421.5B | 97.8B | -5.97% | -1.12% | 32.29 | 4.31 | 2.29% | -28.92% |
MRK | 272.8B | 58.3B | -1.68% | 25.60% | 17.88 | 4.63 | 2.00% | -81.24% |
PFE | 191.9B | 77.9B | -7.28% | -24.56% | 8.94 | 2.46 | -23.04% | -26.74% |
BMY | 150.1B | 45.2B | -5.53% | -15.83% | 23.72 | 3.25 | -4.15% | 20.34% |
MID-CAP | ||||||||
RETA | 6.5B | - | 1.68% | 536.50% | -74 | 4.1K | -86.94% | 71.24% |
PRGO | 4.5B | 4.6B | -12.08% | -16.86% | -67.03 | 0.98 | 6.60% | 42.04% |
SMALL-CAP | ||||||||
TLRY | 1.9B | 627.1M | -7.75% | -1.79% | -1.34 | 3.1 | -0.20% | -204.67% |
SUPN | 1.5B | 634.0M | -8.17% | -19.68% | 35.6 | 2.43 | 0.62% | -24.59% |
CRON | 842.2M | 109.5M | 18.82% | -27.78% | -5.87 | 7.69 | -2.66% | -32.13% |
INVA | 814.0M | 244.3M | -8.50% | 0.08% | 4.13 | 3.33 | -39.50% | -4.99% |
CGC | 567.0M | 453.3M | 123.19% | -68.11% | -0.46 | 1.25 | -16.04% | 55.90% |
ACRS | 523.7M | 31.2M | 3.50% | -46.76% | -4.97 | 16.8 | 407.54% | -26.47% |
OCUL | 269.4M | 54.6M | -19.05% | -43.62% | -2.97 | 4.93 | 9.39% | -179.16% |
ENDP | - | 2.2B | - | - | - | - | -22.39% | 63.59% |
-22.9%
-16.1%
-20.9%
-23.4%
97.3%
72.7%
46.9%
Y-axis is the maximum loss one would have experienced if Bausch Health Companies was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 2.5% | 8,350,000,000 | 8,150,000,000 | 8,124,000,000 | 8,127,000,000 | 8,192,000,000 | 8,325,000,000 | 8,434,000,000 | 8,451,000,000 | 8,478,000,000 | 8,042,000,000 | 8,027,000,000 | 8,038,000,000 | 8,109,000,000 | 8,597,000,000 | 8,601,000,000 | 8,498,000,000 | 8,425,000,000 | 8,401,000,000 | 8,380,000,000 | 8,422,000,000 | 8,505,000,000 |
S&GA Expenses | 1.3% | 2,763,000,000 | 2,728,000,000 | 2,625,000,000 | 2,639,000,000 | 2,631,000,000 | 2,640,000,000 | 2,624,000,000 | 2,580,000,000 | 2,499,000,000 | 2,340,000,000 | 2,367,000,000 | 2,399,000,000 | 2,475,000,000 | 2,600,000,000 | 2,554,000,000 | 2,512,000,000 | 2,478,000,000 | 2,469,000,000 | 2,473,000,000 | 2,486,000,000 | 2,495,000,000 |
EBITDA | -100.0% | - | 2,587,000,000 | 2,729,000,000 | 3,146,000,000 | 2,936,000,000 | 2,406,000,000 | 1,954,000,000 | 1,640,000,000 | 1,576,000,000 | 1,906,000,000 | 2,425,000,000 | 1,425,000,000 | 1,400,000,000 | 1,733,000,000 | 1,850,000,000 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.32 | 0.34 | 0.39 | 0.36 | 0.29 | 0.23 | 0.19 | 0.19 | 0.24 | 0.30 | 0.18 | 0.17 | 0.20 | 0.22 | - | - | - | - | - | - |
Interest Expenses | -6.5% | 1,318,000,000 | 1,409,000,000 | 1,464,000,000 | 1,500,000,000 | 1,466,000,000 | 1,420,000,000 | 1,426,000,000 | 1,462,000,000 | 1,485,000,000 | 1,506,000,000 | 1,534,000,000 | 1,546,000,000 | 1,578,000,000 | 1,602,000,000 | 1,612,000,000 | 1,628,000,000 | 1,630,000,000 | 1,624,000,000 | 1,685,000,000 | - | - |
Earnings Before Taxes | 113.7% | 25,000,000 | -183,000,000 | -129,000,000 | 249,000,000 | 26,000,000 | -515,000,000 | -1,024,000,000 | -1,439,000,000 | -1,580,000,000 | -1,347,000,000 | -934,000,000 | -2,010,000,000 | -2,151,000,000 | -1,893,000,000 | -1,837,000,000 | -793,000,000 | -1,027,000,000 | -1,582,000,000 | -4,154,000,000 | -4,532,000,000 | -4,632,000,000 |
EBT Margin | 100.0% | - | -0.02 | -0.02 | 0.03 | 0.00 | -0.06 | -0.12 | -0.17 | -0.19 | -0.17 | -0.12 | -0.25 | -0.27 | -0.22 | -0.21 | - | - | - | - | - | - |
Net Income | 47.9% | -186,000,000 | -357,000,000 | -225,000,000 | 254,000,000 | 43,000,000 | -407,000,000 | -948,000,000 | -1,170,000,000 | -1,287,000,000 | -1,018,000,000 | -560,000,000 | -1,923,000,000 | -2,043,000,000 | -1,888,000,000 | -1,788,000,000 | -616,000,000 | -917,000,000 | -1,619,000,000 | -4,148,000,000 | -3,291,000,000 | -1,640,000,000 |
Net Income Margin | 100.0% | - | -0.04 | -0.03 | 0.03 | 0.01 | -0.05 | -0.11 | -0.14 | -0.15 | -0.13 | -0.07 | -0.24 | -0.25 | -0.22 | -0.21 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -730,000,000 | -946,000,000 | -1,409,000,000 | 409,000,000 | 671,000,000 | 1,157,000,000 | 1,525,000,000 | 1,199,000,000 | 997,000,000 | 809,000,000 | 651,000,000 | 908,000,000 | 1,054,000,000 | 1,231,000,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 0.2% | 25,503 | 25,445 | 25,686 | 26,298 | 28,171 | 29,090 | 29,202 | 29,252 | 30,042 | 30,197 | 31,199 | 31,562 | 31,396 | 32,630 | 33,863 | 31,667 | 32,354 | 32,551 | 32,492 | 33,777 | 34,448 |
Current Assets | 5.3% | 4,461 | 4,237 | 4,247 | 4,010 | 5,417 | 5,836 | 5,607 | 5,324 | 5,450 | 5,392 | 5,342 | 5,671 | 5,278 | 5,504 | 6,969 | 4,305 | 4,467 | 4,275 | 4,211 | 4,742 | 4,639 |
Cash Equivalents | 11.8% | 579 | 518 | 564 | 486 | 659 | 1,249 | 2,119 | 690 | 642 | 679 | 605 | 977 | 896 | 912 | 3,244 | 825 | 878 | 782 | 721 | 973 | 838 |
Inventory | 1.5% | 1,240 | 1,222 | 1,090 | 1,056 | 1,073 | 1,045 | 993 | 1,058 | 1,086 | 1,076 | 1,094 | 1,224 | 1,226 | 1,124 | 1,107 | 1,100 | 1,060 | 1,012 | 934 | 971 | 993 |
Net PPE | 0.2% | 1,599 | 1,596 | 1,600 | 1,507 | 1,545 | 1,579 | 1,598 | 1,584 | 1,590 | 1,556 | 1,567 | 1,550 | 1,496 | 1,450 | 1,466 | 1,390 | 1,372 | 1,341 | 1,353 | 1,341 | 1,355 |
Goodwill | 0.4% | 11,628 | 11,579 | 11,547 | 12,044 | 12,266 | 12,427 | 12,457 | 12,477 | 12,527 | 12,485 | 13,044 | 13,160 | 13,084 | 13,034 | 13,126 | 13,052 | 13,160 | 13,121 | 13,142 | 13,290 | 13,283 |
Liabilities | -0.3% | 25,232 | 25,300 | 25,426 | 25,865 | 27,918 | 29,231 | 29,236 | 29,387 | 30,653 | 30,321 | 30,594 | 30,907 | 30,850 | 31,075 | 32,727 | 29,107 | 29,666 | 29,772 | 29,677 | 30,540 | 30,890 |
Current Liabilities | 1.1% | 3,967 | 3,923 | 3,941 | 3,831 | 4,997 | 4,774 | 5,198 | 5,437 | 5,517 | 4,898 | 4,913 | 4,732 | 4,718 | 4,886 | 6,248 | 3,735 | 3,705 | 3,941 | 3,836 | 4,162 | 4,074 |
LT Debt, Current | -0.4% | 444 | 446 | 432 | 411 | 150 | - | - | - | - | - | - | - | 1.00 | 4.00 | 1,234 | 100 | 56.00 | 257 | 228 | 298 | 230 |
LT Debt, Non Current | -0.5% | 20,108 | 20,207 | 20,334 | 20,804 | 21,664 | 23,168 | 22,654 | 22,358 | 23,439 | 23,738 | 23,925 | 24,343 | 24,357 | 24,424 | 24,661 | 23,466 | 24,023 | 23,924 | 24,077 | 24,433 | 24,858 |
Shareholder's Equity | 86.9% | 271 | 145 | 260 | - | 253 | -141 | -34.00 | - | - | - | 605 | 655 | 546 | 790 | 1,136 | 2,560 | 2,688 | 2,779 | 2,815 | 3,237 | 3,558 |
Retained Earnings | 0.3% | -9,361 | -9,387 | -9,186 | -8,776 | -9,175 | -9,030 | -8,961 | -9,030 | -9,218 | -8,623 | -8,013 | -7,860 | -7,931 | -7,605 | -7,452 | -5,936 | -5,887 | -5,716 | -5,664 | -5,320 | -4,970 |
Additional Paid-In Capital | 9.9% | 188 | 171 | 159 | 129 | 104 | 415 | 462 | 437 | 413 | 393 | 454 | 435 | 411 | 396 | 429 | 406 | 384 | 374 | 413 | 409 | 391 |
Shares Outstanding | 0.1% | 364 | 364 | 362 | 362 | 362 | 361 | 359 | 360 | 359 | 357 | 355 | 356 | 355 | 353 | 353 | 352 | 352 | 351 | 351 | 352 | 351 |
Minority Interest | -1.2% | 934 | 945 | 952 | 958 | 946 | 75.00 | 72.00 | 69.00 | 76.00 | 73.00 | 70.00 | 68.00 | 72.00 | 71.00 | 73.00 | 78.00 | 87.00 | 86.00 | 82.00 | 84.00 | 91.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 16.2% | -428 | -511 | -728 | -1,179 | 648 | 920 | 1,426 | 1,796 | 1,488 | 1,293 | 1,111 | 951 | 1,210 | 1,349 | 1,501 | 1,586 | 1,593 | 1,476 | 1,501 | 1,760 | 1,728 |
Share Based Compensation | 5.2% | 142 | 135 | 126 | 124 | 124 | 129 | 128 | 119 | 113 | 109 | 105 | 106 | 105 | 105 | 102 | 99.00 | 95.00 | 90.00 | 87.00 | 82.00 | 79.00 |
Cashflow From Investing | 8.6% | -297 | -325 | -303 | -247 | 394 | 409 | 409 | 405 | -253 | -277 | -261 | -262 | -265 | -256 | -419 | -396 | -318 | -351 | -196 | -44.00 | 820 |
Cashflow From Financing | 47.0% | -574 | -1,084 | -474 | 77.00 | -1,044 | -802 | -1,513 | -2,291 | -1,251 | -1,016 | -2,294 | 464 | 107 | 72.00 | 1,443 | -1,314 | -1,226 | -1,215 | -1,353 | -2,693 | -3,737 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues | ||||
Revenues | $ 2,167 | $ 1,967 | $ 4,111 | $ 3,885 |
Expenses | ||||
Selling, general and administrative | 711 | 676 | 1,436 | 1,298 |
Research and development | 156 | 127 | 299 | 254 |
Amortization of intangible assets | 269 | 302 | 542 | 612 |
Goodwill impairments | 0 | 83 | 0 | 83 |
Asset impairments | 37 | 6 | 50 | 14 |
Restructuring, integration, separation and IPO costs | 16 | 35 | 26 | 48 |
Other (income) expense, net | (83) | 0 | (60) | 2 |
Total expenses | 1,755 | 1,806 | 3,524 | 3,439 |
Operating income | 412 | 161 | 587 | 446 |
Interest income | 7 | 3 | 13 | 5 |
Interest expense | (319) | (410) | (626) | (772) |
Gain on extinguishment of debt | 0 | 113 | 0 | 113 |
Foreign exchange and other | (21) | 4 | (31) | (3) |
Income (loss) before income taxes | 79 | (129) | (57) | (211) |
(Provision for) benefit from income taxes | (52) | (10) | (125) | 6 |
Net income (loss) | 27 | (139) | (182) | (205) |
Net (income) loss attributable to noncontrolling interest | (1) | (6) | 7 | (9) |
Net income (loss) attributable to Bausch Health Companies Inc. | $ 26 | $ (145) | $ (175) | $ (214) |
Earnings (loss) per share attributable to Bausch Health Companies Inc. | ||||
Basic (in usd per share) | $ 0.07 | $ (0.40) | $ (0.48) | $ (0.59) |
Diluted (in usd per share) | $ 0.07 | $ (0.40) | $ (0.48) | $ (0.59) |
Weighted-average common shares | ||||
Basic (in shares) | 364.8 | 362.2 | 364.1 | 361.5 |
Diluted (in shares) | 367.1 | 362.2 | 364.1 | 361.5 |
Product sales | ||||
Revenues | ||||
Revenues | $ 2,146 | $ 1,944 | $ 4,068 | $ 3,835 |
Expenses | ||||
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues | 640 | 568 | 1,212 | 1,104 |
Other revenues | ||||
Revenues | ||||
Revenues | 21 | 23 | 43 | 50 |
Expenses | ||||
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues | $ 9 | $ 9 | $ 19 | $ 24 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 579 | $ 564 |
Restricted cash | 9 | 27 |
Trade receivables, net | 1,743 | 1,790 |
Inventories, net | 1,240 | 1,090 |
Prepaid expenses and other current assets | 890 | 776 |
Total current assets | 4,461 | 4,247 |
Property, plant and equipment, net | 1,599 | 1,600 |
Intangible assets, net | 5,299 | 5,800 |
Goodwill | 11,628 | 11,547 |
Deferred tax assets, net | 2,191 | 2,166 |
Other non-current assets | 325 | 326 |
Total assets | 25,503 | 25,686 |
Current liabilities: | ||
Accounts payable | 515 | 521 |
Accrued and other current liabilities | 3,008 | 2,988 |
Current portion of long-term debt | 444 | 432 |
Total current liabilities | 3,967 | 3,941 |
Acquisition-related contingent consideration | 197 | 208 |
Non-current portion of long-term debt | 20,108 | 20,334 |
Deferred tax liabilities, net | 215 | 202 |
Other non-current liabilities | 745 | 741 |
Total liabilities | 25,232 | 25,426 |
Commitments and contingencies (Note 17) | ||
Equity | ||
Common shares, no par value, unlimited shares authorized, 364,063,514 and 361,898,846 issued and outstanding at June 30, 2023 and December 31, 2022, respectively | 10,412 | 10,391 |
Additional paid-in capital | 188 | 159 |
Accumulated deficit | (9,361) | (9,186) |
Accumulated other comprehensive loss | (1,902) | (2,056) |
Total Bausch Health Companies Inc. shareholders’ deficit | (663) | (692) |
Noncontrolling interest | 934 | 952 |
Total equity | 271 | 260 |
Total liabilities and equity | $ 25,503 | $ 25,686 |